NUTM1 and lung cancer: Thus, although we cannot exclude misclassification of SBC-3 cells, our preclinical data support evidence that functional NUTM1 fusions are present in tumours diagnosed as lung cancer, and could represent an actionable driver event in these tumours with immediate potential clinical implications.